Deferasirox in Indian children with thalassemia major: 3 years experience

類似資料

• Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major
  著者:: Pennell, Dudley J., 等
  出版事項: (2012)
• Folate supplementation in transfusion-dependent thalassemia: Do we really need such high doses?
  著者:: Tripathi, Gaurav, 等
  出版事項: (2016)
• Deferasirox: Over a Decade of Experience in Thalassemia
  著者:: Moukalled, Nour M., 等
  出版事項: (2018)
• Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major
  著者:: Musallam, Khaled M., 等
  出版事項: (2011)
• Deferiprone or deferasirox for cardiac siderosis in β thalassemia major (reply)
  著者:: Pepe, Alessia, 等
  出版事項: (2011)